198 related articles for article (PubMed ID: 10739385)
21. High sensitivity enzyme-linked immunosorbent assay (ELISA) method for measuring protein carbonyl in samples with low amounts of protein.
Alamdari DH; Kostidou E; Paletas K; Sarigianni M; Konstas AG; Karapiperidou A; Koliakos G
Free Radic Biol Med; 2005 Nov; 39(10):1362-7. PubMed ID: 16257645
[TBL] [Abstract][Full Text] [Related]
22. Use of biotinylated 17beta-estradiol in enzyme-immunoassay development: spacer length and chemical structure of the bridge are the main determinants in simultaneous streptavidin-antibody binding.
Lacorn M; Fleischer K; Willig S; Gremmel S; Steinhart H; Claus R
J Immunol Methods; 2005 Feb; 297(1-2):225-36. PubMed ID: 15777945
[TBL] [Abstract][Full Text] [Related]
23. Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency.
Ajzner E; Schlammadinger A; Kerényi A; Bereczky Z; Katona E; Haramura G; Boda Z; Muszbek L
Blood; 2009 Jan; 113(3):723-5. PubMed ID: 18955560
[TBL] [Abstract][Full Text] [Related]
24. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
[TBL] [Abstract][Full Text] [Related]
25. A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen.
Giri TK; Hillarp A; Härdig Y; Zöller B; Dahlbäck B
Thromb Haemost; 1998 Apr; 79(4):767-72. PubMed ID: 9569190
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a sensitive colorimetric FXIII incorporation assay. Effects of FXIII Val34Leu, plasma fibrinogen concentration and congenital FXIII deficiency.
Wilmer M; Rudin K; Kolde H; Poetzsch B; Lenz W; Moessmer G; Meili E; Egbring R; Gempeler-Messina P; Gempeler M; Bastian S; Kohler H
Thromb Res; 2001 Apr; 102(1):81-91. PubMed ID: 11323018
[TBL] [Abstract][Full Text] [Related]
27. Determination of matrix metalloproteinase activity using biotinylated gelatin.
Ratnikov B; Deryugina E; Leng J; Marchenko G; Dembrow D; Strongin A
Anal Biochem; 2000 Nov; 286(1):149-55. PubMed ID: 11038285
[TBL] [Abstract][Full Text] [Related]
28. A coagulation factor becomes useful in the study of acute leukemias: studies with blood coagulation factor XIII.
Kiss F; Simon A; Csáthy L; Hevessy Z; Katona E; Kiss C; Kappelmayer J
Cytometry A; 2008 Mar; 73(3):194-201. PubMed ID: 18000871
[TBL] [Abstract][Full Text] [Related]
29. Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism.
Mezei ZA; Katona É; Kállai J; Bereczky Z; Molnár É; Kovács B; Ajzner É; Bagoly Z; Miklós T; Muszbek L
Thromb Res; 2016 Dec; 148():101-106. PubMed ID: 27821352
[TBL] [Abstract][Full Text] [Related]
30. Male-specific cardiac pathologies in mice lacking either the A or B subunit of factor XIII.
Souri M; Koseki-Kuno S; Takeda N; Yamakawa M; Takeishi Y; Degen JL; Ichinose A
Thromb Haemost; 2008 Feb; 99(2):401-8. PubMed ID: 18278192
[TBL] [Abstract][Full Text] [Related]
31. Antibodies against Noncatalytic B Subunit of Factor XIII Inhibit Activation of Factor XIII and Fibrin Crosslinking.
Souri M; Yokoyama C; Osaki T; Ichinose A
Thromb Haemost; 2023 Sep; 123(9):841-854. PubMed ID: 36934722
[TBL] [Abstract][Full Text] [Related]
32. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
Hellstern P; Schilz K; von Blohn G; Wenzel E
Thromb Haemost; 1983 Aug; 50(2):563-6. PubMed ID: 6138878
[TBL] [Abstract][Full Text] [Related]
33. Leukemic lymphoblasts, a novel expression site of coagulation factor XIII subunit A.
Kiss F; Hevessy Z; Veszprémi A; Katona E; Kiss C; Vereb G; Muszbek L; Kappelmayer JN
Thromb Haemost; 2006 Aug; 96(2):176-82. PubMed ID: 16894461
[TBL] [Abstract][Full Text] [Related]
34. Physiopathology and regulation of factor XIII.
Ichinose A
Thromb Haemost; 2001 Jul; 86(1):57-65. PubMed ID: 11487042
[TBL] [Abstract][Full Text] [Related]
35. [Congenital factor XIII deficiency required high-dose factor XIII concentrate in late pregnancy].
Takahashi T; Hatao K; Suzukawa M; Oji T
Rinsho Ketsueki; 2007 May; 48(5):418-20. PubMed ID: 17571589
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of a simple and direct ELISA method for the determination of conjugated (glucuronide) and non-conjugated testosterone excretion in urine.
Al-Dujaili EA
Clin Chim Acta; 2006 Feb; 364(1-2):172-9. PubMed ID: 16098502
[TBL] [Abstract][Full Text] [Related]
37. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P
Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
[TBL] [Abstract][Full Text] [Related]
38. Agreement between factor XIII activity and antigen assays in measurement of factor XIII: A French multicenter study of 147 human plasma samples.
Caron C; Meley R; Le Cam Duchez V; Aillaud MF; Lavenu-Bombled C; Dutrillaux F; Flaujac C; Ryman A; Ternisien C; Lasne D; Galinat H; Pouplard C
Int J Lab Hematol; 2017 Jun; 39(3):279-285. PubMed ID: 28318109
[TBL] [Abstract][Full Text] [Related]
39. Factor XIII Assays and associated problems for laboratory diagnosis of factor XIII deficiency: an analysis of International Proficiency testing results.
Hsu P; Zantek ND; Meijer P; Hayward CP; Brody J; Zhang X; Smock KJ; Van Cott EM
Semin Thromb Hemost; 2014 Mar; 40(2):232-8. PubMed ID: 24497117
[TBL] [Abstract][Full Text] [Related]
40. Aggressive fatal case of autoimmune hemorrhaphilia resulting from anti-Factor XIII antibodies.
Sugiyama H; Uesugi H; Suzuki S; Tanaka K; Souri M; Ichinose A
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):85-9. PubMed ID: 23183237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
